Healthcare Services

Anaphylaxis Market Global Report 2026 Market Forecast 2026–2035 Reflecting Expansion Opportunities Across Industries

March 30, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Much Is The Anaphylaxis Market Expected To Grow In Terms Of Market Value Between 2026 And 2030?

The anaphylaxis market size has experienced robust growth over recent years. Projections indicate it will expand from $3.5 billion in 2025 to $3.79 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 8.2%. Historically, this expansion is attributable to several factors, including the rising incidence of food and drug allergies, an increased diagnosis of allergic conditions, the widespread availability of emergency epinephrine treatments, growing public health awareness, and the adoption of standardized treatment guidelines.

The anaphylaxis market size is anticipated to demonstrate significant expansion in the coming years, projected to reach $5.14 billion by 2030, at a compound annual growth rate (CAGR) of 7.9%. This growth throughout the forecast period stems from various factors including enhanced access to emergency allergy care, an increasing need for portable treatment solutions, the expansion of allergy specialty services, a heightened focus on patient education initiatives, and greater investment in allergy management infrastructure. Prominent trends for the forecast period encompass the growing availability of epinephrine auto-injectors, increased awareness concerning severe allergic reactions, a stronger emphasis on emergency preparedness, the broadening of allergy diagnosis and monitoring capabilities, and an improved focus on rapid response protocols.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21096&type=smp

What Major Drivers Are Influencing Demand In The Anaphylaxis Market?

The increasing occurrence of food allergies is anticipated to drive the expansion of the anaphylaxis market in the coming years. Food allergies are immune system responses triggered by specific foods, manifesting in symptoms from mild to severe, including life-threatening anaphylaxis. This rising prevalence stems from factors such as changing dietary habits, environmental influences, and enhanced awareness and diagnosis. Anaphylaxis treatment provides crucial, life-saving intervention for food allergy patients by swiftly reversing severe allergic reactions, diminishing symptoms like swelling, difficulty breathing, and a drop in blood pressure, thus ensuring immediate stabilization and preventing potentially fatal outcomes. It also empowers patients with the means for timely action in future allergic incidents. For instance, in September 2024, the World Health Organization (WHO), a Switzerland-based United Nations (UN) organization, indicated that around 220 million people globally are affected by food allergies. A single food product can contain multiple allergens, and individuals might be allergic to more than one type of food. Additionally, a report published in May 2024, the Patterns and Prevalence of Adult Food Allergy (PAFA) by the Food Standards Agency (FSA), a UK-based non-ministerial department, revealed that over 30% of adults reported food-related adverse reactions, and clinical assessments confirmed food allergies in approximately 6% of UK adults, totaling around 2.4 million people. Therefore, the growing incidence of food allergies is fueling the growth of the anaphylaxis market.

What Major Segment Divisions Exist Within The Anaphylaxis Market?

The anaphylaxis market covered in this report is segmented –

1) By Drug Class: Epinephrine, Steroids, Antihistamines, Other Drug Class

2) By Route Of Administration: Parenteral, Oral, Other Routes Of Administration

3) By Application: Food Allergy, Pollen Allergy, Dust Mites Allergy, Other Applications

Subsegments:

1) By Epinephrine: Auto-injectors, Prefilled Syringes, Vials

2) By Steroids: Corticosteroids, Glucocorticoids, Mineralocorticoids

3) By Antihistamines: H1-receptor Antagonists, H2-receptor Antagonists

4) By Other Drug Class: Leukotriene Receptor Antagonists, Mast Cell Stabilizers

How Are Trends Shaping The Direction Of The Anaphylaxis Market?

Key players within the anaphylaxis market are concentrating on developing advanced epinephrine nasal spray products, which facilitate more rapid and effective drug administration in emergencies. An epinephrine nasal spray is a medical instrument that delivers epinephrine (adrenaline) via the nasal passages to manage severe allergic reactions, including anaphylaxis. For example, in August 2024, ARS Pharmaceuticals, a US-based biotechnology firm, announced that Neffy (epinephrine nasal spray) received approval from the Food and Drug Administration, a US-based government entity, establishing it as the initial and sole needle-free treatment for type I allergic reactions, including anaphylaxis. This inventive nasal spray offers a non-invasive substitute to traditional epinephrine autoinjectors, presenting a potentially more reachable solution for emergency intervention. Neffy endeavors to boost patient cooperation by removing the necessity for needles, while still supplying prompt, critical epinephrine during severe allergic responses.

Which Companies Are Leading Innovation In The Anaphylaxis Market?

Major companies operating in the anaphylaxis market are Pfizer Inc., Johnson & Johnson Services Inc., Merck & Co. Inc., Bayer AG, Novartis AG, Sanofi SA, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline Plc, F. Hoffman-La Roche Ltd., Teva Pharmaceutical Industries Ltd., Bausch Health Companies Inc., Perrigo Company plc, Dr Reddy’s Laboratories Ltd., Cipla Ltd., Amneal Pharmaceuticals Inc., Mylan N.V., ALK-Abelló, Stallergenes Greer, Allergy Therapeutics

Read the full anaphylaxis market report here:

https://www.thebusinessresearchcompany.com/report/anaphylaxis-global-market-report

Which Region Shows The Strongest Potential For Future Growth In The Anaphylaxis Market?

North America was the largest region in the anaphylaxis market in 2025. The regions covered in the anaphylaxis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Anaphylaxis Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=21096&type=smp

Browse Through More Reports Similar to the Global Anaphylaxis Market 2026, By The Business Research Company

inhalable drugs global market report

https://www.thebusinessresearchcompany.com/report/inhalable-drugs-global-market-report

asthma drugs global market report

https://www.thebusinessresearchcompany.com/report/asthma-drugs-global-market-report

allergic rhinitis drugs global market report

https://www.thebusinessresearchcompany.com/report/allergic-rhinitis-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795